In a new op-ed for @devex.com, our CEO, Anne Aslett and Gilead Sciences CEO, Daniel O’Day reflect on RADIAN’s impact - a partnership we launched in 2019 to tackle HIV in Eastern Europe and Central Asia, one of the few regions where HIV cases are rising. Read the full op-ed: bit.ly/4hou7iu
